-+ 0.00%
-+ 0.00%
-+ 0.00%

Eli Lilly completed the acquisition of Ataibekley to advance research and development of treatments for intractable depression and other mental illnesses.

智通財經·09/11/2026 13:09:03
語音播報
Eli Lilly completed the acquisition of Ataibekley to advance research and development of treatments for intractable depression and other mental illnesses.